10/14 Flashcards

1
Q

HTN diagnosis

A

-Often asymptomatic (may observe dizziness or headache)
-Two or more measurements of blood pressure with
diastolic pressure > 90 mm Hg, Systolic pressure > 140 mm Hg
-Pulse Pressure (SBP-DBP) > 65 mm Hg VERY important
indicator
- >50 yo, SBP > 140 mm Hg very important cardiovascular
disease risk factor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

pre HTN

A

120-139 / 80-89

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

stage 1 HTN

A

140-159 / 90-99

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

stage 2 HTN

A

> 160 / > 100

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

BP = __ x __

A

CO x PVR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

chronic BP is controlled by

A

kidneys

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

angiotensin pathway

A

angiotensinogen -(renin)-> ang I -(ACE)-> ang II

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

normal BP

A

less than 120/80

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

essential or primary HTN

A
  • 85- 90% of cases
  • no identifiable cause
  • increase peripheral vascular resistance (PVR); normal cardiac output (CO)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

essential HTN risk factors

A

FH, sex, diet, smoking, DM, hyperlipidemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

other causes of HTN

A
  • renal artery constriction
  • coarctation of the aorta
  • pheochromocytoma
  • cushing’s
  • primary aldosteronism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

why treat HTN?

A

end organ damage: kidney, heart, brain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

goal of HTN therapy

A

-reduce diastolic BP to reduce incidence of end organ damage
BP = CO x PVR
-reduce CO
-reduce PVR (vasodilation, decrease blood volume)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

actions of ang II

A
  • vasoconstrictor

- stimulates aldosterone release (aldosterone stimulates Na/water retention)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

reserpine MOA

A

inhibits dopamine pump into vesicles, dopamine cant be converted to NE, NE cant be released into the synapse; depletes vascular pool of NE; slow onset of action, sustained effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

reserpine SE

A

GI (diarrhea, cramps, acid secretion), CNS (sedation, nightmares, depression)

17
Q

a2 receptor agonists MOA

A

K+ flows out of cell, hyperpolarization, less chance of response, decrease sympathetic output

18
Q

clonidine class

A

a2 receptor agonists

19
Q

why is clonidine lipophilicty important?

A

must cross BBB to reach medulla

20
Q

clonidine SE

A

dry mouth, sedation, depression, withdrawl syndrome, Na and water detention

21
Q

a1 receptor antagonists

A

vasodilaion, “quinazolines”, prazosin, terazosin, doxazosin

22
Q

a1 receptor antagonists SE

A

“first dose” effect (orthostatic hypotension), Na and water retention, slight tachycardia

23
Q

beta blockers overview

A

dec CO and HR, reduce renin release (beta1 receptors in kidney), recheck lipids after 3-4 months (transient changes), hypoglycemia, bronchial resistance

24
Q

cardio selective B blockers

A

metoprolol, atenolol,

25
Q

3rd generation B blockers

A

Nebivolol - B blocking action and vasodilation due to nitric oxide production

26
Q

B blockers SE

A

bradycardia, AV block, sedation, mask hypoglycemia, withdrawl symptoms (upregulation of receptors), minimal compensatory responses

27
Q

B blockers CI

A

asthma, COPD, CHF (IV)

28
Q

mixed adrenergic receptor antagonists

A

labetalol, carvidilol

B and a1 receptors antagonist, racemic mixture, vasodilator (a1), dec renin release (B)